Your patients have read the headlines about counterfeit and contaminated GLP-1 and peptide product. They walk in already suspicious. A scan on the vial opens the documentation record for that exact lot, before the injection.
The job, in four moves
The code on the Seal opens the record for their exact lot: what the certificate reports, who established each line, the chain to your chair.
Scan the release slip once and every vial lands on that site’s desk, accept or hold with the reasons stated. The same screen at every location.
Writes the administration line with the site’s own visit reference. No name enters the record.
The lot is named on every desk holding it. You see which sites opened the notice. Patients who saved their vial are notified through their own account.
The Seal carries no Veritura mark and no grade. It opens a record that says what the paperwork established and what it did not.
01
A QR on the released seal opens the customer-facing Evidence Passport for their exact order and lot. They read product, lot, what the certificate reports, and who established each line, on their phone, before the injection. Trust me is what a counterfeit seller says too; this is the moment the record does the talking.
The scan happens before the injection, on the patient's own phone, and what it shows is the documentation record for that exact lot rather than a claim from the counter.
02
Documentation completeness reaches the patient as one of four sentences. There is no posture word on that page and no number, because a customer surface is built to a different rule than the workspace: values and provenance labels only, with nothing on it that a patient could mistake for a grade of the medicine.
One of four plain sentences, no score and no posture word, is what keeps a customer surface from being mistaken for a grade of the medicine.
03
Every lot you carry is watched against live FDA recall and enforcement records, so a later notice reaches you and every linked record. Selling the vial is not the end of your duty to the patient, and a patient who saved their vial can be reached directly, PHI-free, if a notice ever lands on that lot.
Every lot you carry is watched for as long as you carry it, so a later notice reaches you and every linked record, and the patients who saved a vial can be reached directly.
04
Anything about treatment stays with the dispensing clinician or pharmacy. The record answers what the documentation says and nothing about a patient's care. Corrections route to Veritura with the report ID and the document that supports the change, and a supported observation is never removed for being unfavourable.
Corrections need a supporting document and are never removed for being unfavourable, and questions about care stay with the clinician, not with the record.
Why this exists
Federal law requires that bulk substances used in compounding be accompanied by a valid certificate of analysis, and names no method for establishing that a certificate is valid. Every pharmacy, facility, clinic, and platform in the chain is left to decide for itself. That gap is the whole reason an independent evidence layer exists.
The requirement appears in the federal compounding provisions for both 503A pharmacies and 503B outsourcing facilities. Validity is required. A way to establish it is not described.
In 2026 the FDA published a warning letter to a bulk supplier on its own published lists, describing relabelled active ingredient and altered manufacturing and retest dates. A buyer who checked the list and received a certificate still held a document that did not say what it appeared to say.
A large telehealth provider ran a per-batch certificate lookup from a code in each shipment for over a year and reported thousands of subscribers opening it every month. The demand for the record is not the question. Who checks it is.
Where the patient’s contact lives
Two records, one join. The clinic’s administration line carries the unit, the lot, the date and the clinic’s own visit reference, and nothing else. A patient who scans the vial can save it to their own space with an email they type themselves. That email lives in the patient’s account, never in the clinic’s record, and Veritura never joins the two.
No name, chart or contact. The reference is yours, and Veritura never asks what it means. The log a board asks a clinic to produce is this line, per vial, per visit.
Scanning the vial and saving it creates the patient’s own space. The email is held there, for their notices, and is never written to the clinic’s or the pharmacy’s record.
Saved vials are reached through the patient’s own account. Everyone else is reached through the order list your clinic already holds. Nothing about a patient is stored to make the first path work.
What changes
A scan on the vial opens the record for that exact lot before the injection.
Issued by a party that does not sell the medicine and never sells placement, with no score and no posture word.
Every lot you carry watched, and patients who saved a vial reachable.
They are not asking you to be more confident. They are asking to see something.
Veritura does not sell, source, or distribute product, so the record does not rest on your say-so.
Every lot you carry is watched against live FDA recall and enforcement records, and a match flags the linked lots, orders, and vials.
Read the compounder's documentation before you buy, against a six-element supplier file with a living status.
No cGMP paperwork and no API bench. This is the trust layer for the product you carry.
The complete text, for the reader who wants the whole story before a call.
They are not asking you to be more confident. They are asking to see something.
Your patients have read the headlines about counterfeit and contaminated GLP-1 and peptide product. They walk in already suspicious, and the gray-market seller down the road undercuts you on price.
You keep the paperwork on file. You have no way to show it in the moment, and "trust me" is exactly what a counterfeit seller says too.
Veritura puts an independent documentation record for the exact lot in the patient's hand, issued by a party that does not sell, source, or distribute the product.
How it works for you
A QR on the released seal opens the customer-safe Evidence Passport for their exact order and lot.
Product, lot, what the certificate reports, and who established each line, on their phone before the injection.
Every lot you carry is watched against live FDA recall and enforcement records, so a later notice reaches you and every linked record.
Serialized labels are minted against a lot, printed, applied to the vial, and scanned by whoever holds it. One button then reaches every person who saved one.
A lot is ready to go out the door.
Serials are minted against that lot in the shape VS-XXXX-XXXX, collision-checked against every serial already issued and against the batch's own output. When order references are supplied, each serial is bound one-to-one to one order at mint time.
Labels print as an Avery sheet, as single thermal labels, or as raw ZPL fed straight to the printer. The QR is the printer's own symbol at a magnification that clears the quiet-zone requirement on all four sides.
The label goes on the vial. Where serials were bound to orders, packing becomes the same label-to-packing-slip match the pharmacy already performs for addresses.
The person holding the vial scans the QR or types the serial.
The public page at /u/<serial> shows the substance, the lot, what the certificate stated, the lab and the date, plus the verify link when the lot has a released production passport. Values and provenance labels only: no report ids, no file names, no hashes. The certificate stays with the pharmacy.
The person chooses to save the vial.
An email is entered. The claim starts at pending_confirm and only the emailed link activates it. Two or more simultaneously active claims on one serial is surfaced as the same-seal-claimed-twice signal.
Something changes on the lot's documentation record.
One button reaches every active claimant across every seal batch of that lot, deduped so one address gets one notice, each deep-linked to that person's own vial page. One notify per lot per hour.
A claim stores an email, a serial, a status and timestamps. There is no field for a name, an address, a condition or a prescriber, so there is nothing to leak.
At most five live claims on one serial, at most ten claim requests from one address per day, and a global daily ceiling on confirmation emails.
A notice says the documentation record changed. It is not a safety or quality determination, and the notice tells the reader to contact their pharmacy or provider with any medication question.
What the patient sees
The scan opens the customer-safe Passport for the represented order and lot. It shows what the paperwork reports, where each status came from, the notice state, and the explicit limits.
Sample data · not a live account
SupplierAurora Pharma Supply
OrderPO-DEMO-0413
ReleasedJuly 23, 2026
The patient scans the label and sees this, before the injection.
Product and lotAs represented on the paperwork for that exact vial
What the certificate reportsThe documented result, shown as the document states it
Evidence originVeritura evaluated, Operator attested, Source-confirmed, or Human-reviewed
Documentation completeness at issueStated in words, for example documentation reads complete
Notice stateWhether a later public FDA signal has matched the lot
What it does not establishNot a safety, quality, efficacy, legality, or FDA-approval claim
Documentation completeness reaches the patient as one of four sentences. There is no posture word on that page and no number.
A paperwork-completeness read, never a product-quality or safety determination.
The patient page prints the band in words and no numeric score. A number beside the name of someone's medicine reads as a quality grade, which it is not.
Anything about treatment stays with the dispensing clinician or pharmacy. The record answers what the documentation says, and nothing about a patient's care.
Corrections route to Veritura with the report ID, the observation at issue, and the document that supports the change. A supported observation is never removed for being unfavorable.
"Trust me" is what a counterfeit seller says too. Veritura lets the patient scan the vial and read the documentation record for their exact lot. The trust moment at the point of care, in their hand.
Your own word is worth what any other seller's word is worth to a nervous patient: nothing. Veritura does not sell, source, or distribute product, so the record does not rest on your say-so.
Selling the vial is not the end of your duty to the patient. Veritura watches every lot you carry against live FDA recall and enforcement records, and a matched signal flags the linked lots, orders, and Passports.
Stocking on a relationship is stocking on hope. Read the compounder's documentation before you buy, against a 6-element supplier qualification file that carries a living status of Current, Due, Overdue.
Unsure about a vendor's certificate before you commit? The Free plan reads one Certificate of Analysis with no account and no card, and shows what a documentation read turns up.
No cGMP paperwork, no API bench. This is the trust layer for the product you carry.
What the record does not establish
A patient reads these on the same page as the evidence. They are part of the record, never fine print beneath it.
A COA check or Passport records whether the documents are complete and consistent. It is not a safety, quality, efficacy, legality, or FDA-approval claim.
A result is a documentation posture of Clear, Review, or Hold on the document set. A ClearGate decision of Allow, Review, or Hold is a separate axis, resolving one order against the policy you configure. Both describe the paperwork, not the medicine.
Authenticity limits. A report may identify metadata, repeated file signals, links, and inconsistencies. It cannot prove document provenance unless an issuing lab or source independently confirms it.
No purchase recommendation. Reports do not recommend, endorse, discourage, rank, or facilitate purchases from any vendor.
Users should redact patient data, protected health information, patient identifiers, prescription records, nonessential pricing terms, and unrelated commercial information before submitting materials for review.
A QR on the released seal. It opens the customer-facing Passport for their exact order and lot: product, lot, what the certificate reports, and who established each line, before the injection.
Nothing. It answers what the documentation says, in one of four sentences, with no posture word and no number. Treatment questions stay with the clinician.
Yes. Read the compounder's documentation before you buy, against a six-element supplier file with a living current, due, or overdue status.
Still have questions? Talk to a person.
